MediciNova to Initiate Clinical Trial of MN-001 (tipelukast) in IPF
October 09, 2015 at 06:01 AM EDT
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock ...